companydata.dkcompanydata.dk

AGC Biologics A/S: Financial statements 2024

CVR: 25950941

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

AGC Biologics A/S (CVR 25950941) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 2,016,194,000 and a net result of DKK -115,005,000 compared with DKK 243,869,000 the year before. That is a decrease of 3.6% compared with the year before. The profit margin was -5.7%. Equity in the 2024 report amounted to DKK 640,031,000. The solvency ratio was 16.9%. The company had 1,019 employees in the financial year.

Revenue
DKK 2,016,194,000
Gross Profit
DKK 160,194,000
Profit/Loss
DKK -115,005,000
Equity
DKK 640,031,000
Total Assets
DKK 3,788,309,000
Employees
1,019

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20242B160.2M-115M640M1019
20232.1B501.3M243.9M307.4M956
20222.5B937M598.9M661.3M894
20212.2B831.9M571.7M633.6M730
20201.5B452M278.5M339.7M441

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

AGC Biologics A/S: The 2023 annual report is outJul 4, 2024

AGC Biologics A/S has published its annual report for 2023. Revenue came to DKK 2,092,565,000, and the net result was DKK 243,869,000.

Patricio Ezequiel Massera leaves the board of AGC Biologics A/SJun 30, 2024

As of June 30, 2024, Patricio Ezequiel Massera has left the board of directors of AGC Biologics A/S.

Tadashi Murano joins the board of AGC Biologics A/SJan 8, 2024

As of January 8, 2024, Tadashi Murano has joined the board of directors of AGC Biologics A/S.

Noriyuki Komuro leaves the board of AGC Biologics A/SJan 8, 2024

As of January 8, 2024, Noriyuki Komuro has left the board of directors of AGC Biologics A/S.

About AGC Biologics A/S

AGC Biologics A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2001. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named CMC BIOLOGICS A/S and CMC BIOPHARMACEUTICALS A/S. The management consists of Kasper Møller. The board consists of Tadashi Murano (chair), Alberto Santagostino, Kasper Møller and Mai Iwaya. The company is owned by Asahi Glass Co., Ltd.. The company has 1,503 employees (2026). In 2025, the company reported revenue of DKK 1,959,639,000 and a net result of DKK -328,010,000 compared with DKK -115,005,000 the year before. Equity in the 2025 report amounted to DKK 312,021,000.

Source: annual report 2025, Danish Business Authority